Marco is a highly accomplished C-suite executive (CBO/CEO), advisory board member, and qualified pharmacist. He is an expert in driving innovation, strategic growth, and operational excellence within the global biotechnology, MedTech, and pharmaceutical industries.
As an authentic leader with a passion for improving human health through innovation, Marco has a keen insight into emerging trends and technologies. His key strengths include providing strategic guidance and thought leadership as a trusted advisor to executive teams and boards, fostering cross-functional partnerships, and guiding companies through periods of transformation and growth. Marco excels in assembling and leading high-performing teams that exceed expectations in delivering organizational objectives.
He combines a proven track record in business development with expertise in project management, licensing, and negotiation to secure high-value partnership deals. Marco’s deep understanding of business needs, opportunities, risks, and challenges allows him to influence strategy and guide decision-making effectively.Marco holds a Doctor of Pharmacy (DPharm) degree from the University of Siena and a PhD from the University of Cambridge, UK. He also serves as an advisory board member of the Rethink! Foundation.